| Epidemiology and treatment of multiple sclerosis in elderly populations CB Vaughn, D Jakimovski, KS Kavak, M Ramanathan, RHB Benedict, ... Nature Reviews Neurology 15 (6), 329-342, 2019 | 297 | 2019 |
| The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to: in vivo: imaging Y Guan, D Jakimovski, M Ramanathan, B Weinstock-Guttman, ... Neural regeneration research 14 (3), 373-386, 2019 | 198 | 2019 |
| Interferon β for multiple sclerosis D Jakimovski, C Kolb, M Ramanathan, R Zivadinov, B Weinstock-Guttman Cold Spring Harbor perspectives in medicine 8 (11), a032003, 2018 | 176 | 2018 |
| Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine R Zivadinov, D Jakimovski, S Gandhi, R Ahmed, MG Dwyer, D Horakova, ... Expert review of neurotherapeutics 16 (7), 777-793, 2016 | 170 | 2016 |
| Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5‐year longitudinal study D Jakimovski, S Gandhi, I Paunkoski, N Bergsland, J Hagemeier, ... European journal of neurology, 2019 | 103 | 2019 |
| Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study D Jakimovski, R Zivadinov, M Ramanthan, J Hagemeier, ... Multiple Sclerosis Journal 26 (13), 1670-1681, 2020 | 96 | 2020 |
| Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study D Jakimovski, J Kuhle, M Ramanathan, C Barro, D Tomic, J Hagemeier, ... Annals of clinical and translational neurology 6 (9), 1757-1770, 2019 | 89 | 2019 |
| Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings D Jakimovski, Y Guan, M Ramanathan, B Weinstock-Guttman, ... Neurodegenerative disease management 9 (3), 149-172, 2019 | 75 | 2019 |
| Atrophied brain lesion volume: a new imaging biomarker in multiple sclerosis MG Dwyer, N Bergsland, DP Ramasamy, D Jakimovski, ... Journal of Neuroimaging 28 (5), 490-495, 2018 | 75 | 2018 |
| Atrophied brain T2 lesion volume at MRI is associated with disability progression and conversion to secondary progressive multiple sclerosis AV Genovese, J Hagemeier, N Bergsland, D Jakimovski, MG Dwyer, ... Radiology 293 (2), 424-433, 2019 | 69 | 2019 |
| Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study D Jakimovski, B Weinstock-Guttman, S Gandhi, Y Guan, J Hagemeier, ... Journal of neurology 266, 866-875, 2019 | 62 | 2019 |
| Multiple sclerosis in children: differential diagnosis, prognosis, and disease-modifying treatment D Jakimovski, S Awan, SP Eckert, O Farooq, B Weinstock-Guttman CNS drugs 36, 45-59, 2022 | 61 | 2022 |
| Coagulation pathways in neurological diseases: multiple sclerosis N Ziliotto, F Bernardi, D Jakimovski, R Zivadinov Frontiers in Neurology 10, 409, 2019 | 61 | 2019 |
| Aging and brain atrophy in multiple sclerosis E Ghione, N Bergsland, MG Dwyer, J Hagemeier, D Jakimovski, ... Journal of Neuroimaging 29 (4), 527-535, 2019 | 60 | 2019 |
| Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis TA Fuchs, RHB Benedict, A Bartnik, S Choudhery, X Li, M Mallory, ... Human brain mapping 40 (18), 5231-5241, 2019 | 59 | 2019 |
| Cognitive profiles of aging in multiple sclerosis D Jakimovski, B Weinstock-Guttman, S Roy, M Jaworski III, L Hancock, ... Frontiers in aging neuroscience 11, 105, 2019 | 57 | 2019 |
| Complementary and alternative medicine usage by multiple sclerosis patients: results from a prospective clinical study S Kim, L Chang, B Weinstock-Guttman, S Gandhi, D Jakimovski, E Carl, ... The Journal of Alternative and Complementary Medicine 24 (6), 596-602, 2018 | 52 | 2018 |
| Recovery of cognitive function after relapse in multiple sclerosis RHB Benedict, J Pol, F Yasin, D Hojnacki, C Kolb, S Eckert, B Tacca, ... Multiple Sclerosis Journal 27 (1), 71-78, 2021 | 50 | 2021 |
| Infections, vaccines and autoimmunity: a multiple sclerosis perspective D Jakimovski, B Weinstock-Guttman, M Ramanathan, MG Dwyer, ... Vaccines 8 (1), 50, 2020 | 48 | 2020 |
| Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 … N Murali, RW Browne, K Fellows Maxwell, ML Bodziak, D Jakimovski, ... European Journal of Neurology 27 (1), 188-e4, 2020 | 47 | 2020 |
Robert ZivadinovUniversity at Buffalo, State University of New York, United StatesVerifierad e-postadress på bnac.net